0 items USD 0.00Search
Your search for "machine-to-machine (M2M)" gave back 14 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 560.00
Cadherins are a family of glycoproteins responsible for calcium ion鈥揹ependent cell adhesion. There are more than 100 types of cadherins in humans,...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 450.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
This report evaluates G-protein鈥揷oupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 670.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
颁补迟补濒辞驳:听
La Merie Publishing
September 2019
Price: USD 2,350.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research鈥檚 latest report, Global Clinical Trials - Current Trends and...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report 鈥淚nnovation Tracking Factbook...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2018
Price: USD 2,995.00
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research鈥檚 latest report 鈥�...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research鈥檚 latest report,...
颁补迟补濒辞驳:听
CBR Pharma Insights
October 2018
Price: USD 2,995.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research鈥檚 latest...
颁补迟补濒辞驳:听
CBR Pharma Insights
May 2018
Price: USD 2,995.00
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future Summary GBI Research鈥檚 latest report, "...
CBR Pharma Insights
December 2015
Price: USD 2,995.00
听
